《亞洲股市》日經及中韓港股跌0.8%-1.5% 恆指跑輸失二萬五 惟星馬澳股逆彈
美股昨晚個別發展,美國經濟數據繼續表現參差,加上商品價格下挫,其中紐約期油跌2.7%六連跌,逾半藍籌向下,金融、工業及油股沽壓較大,尤其是Nike、運通、Walgreens、陶氏、雪佛龍、卡特彼勒及波音挫1.9%-3.1%,但醫保護理股及受惠債息降的藍籌科技股普遍反彈,尤其是季績勝預期思科漲3.8%,寶潔、微軟及聯合健康升1.2%-2.5%,支持道指由曾跌270點,收窄至僅跌66點三連吐;Tesla回吐逾2%,但奈飛升逾4%,費城半導體指數回升0.8%,支持納指及標普反覆回升0.1%,分別結束三連跌及兩連跌。不過,歐洲主要股市全面追跌1.2%-2.4%,CAC跑輸,但前天升逾1%跑贏西班牙僅吐0.8%。
美股期貨好淡爭持,其中道指期貨報34,797,反覆續跌21點,但納指期貨報14,935,逆市續升7點。亞太區股市早段窄幅個別發展。美匯指數四連升報93.55創九個月高,其中美元兌日圓今早於亞洲微升不足0.1%報109.79,但日本疫情嚴峻,日本連續10個月呈通縮,日經繼昨天回落逾1%後,今早仍反覆受壓,最高見27,316無以為繼,現報27,051,續跌230點或0.8%。
韓股繼昨天急挫1.9%後,今早續跌1.1%報3,062。台灣加權指數繼昨天低收急挫2.7%創近三個月低後,今早續跌0.2%報16,339。
受惠央行意外未有加息的新西蘭50指數繼昨天逆市高收續漲1.9%後,今早高見12,976乏力,現報12,930,倒跌0.2%。
港股繼昨天在新經濟股等主導曾急挫至25,183喘定,收25,316,僅挫550點或2.1%,今早在藥明生物(02269.HK)、中績多賺2.2倍中期股息年增50%的中海油(00883.HK)、昨天急挫美團(03690.HK)/阿里巴巴(09988.HK)低開1.3%-2.5%,抵消中績多賺21%歷來首派中期息12分兼擬分拆智網科技A股上市的聯通(00762.HK)高開5.6%、建行(00939.HK)/申洲(02313.HK)/碧桂園(02007.HK)/石藥(01093.HK)高開逾1%-3%,恆指低開75點或0.3%,跌幅擴至384點或1.5%,報24,931。
滬指繼昨天回吐0.6%後,今早低開近0.7%報3,442,現報3,428,續跌1.1%;深成繼昨天反覆續升0.2%後,今早低開0.8%,現報14,330,回吐1.1%。
相反,當地疫情反彈的澳洲200由紀錄高位四連吐後,今早微升0.2%報7,477。新加坡海峽時報指數扭轉昨天跌1.4%勢,報3,107,回升0.7%。吉隆坡綜合指數回升0.3%報1,519。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.